about
The influence of simvastatin, atorvastatin and high-cholesterol diet on acetylcholinesterase activity, amyloid beta and cholesterol synthesis in rat brain.Preparation and characterization of methoxy polyethylene glycol-conjugated phosphotriesterase as a potential catalytic bioscavenger against organophosphate poisoning.7-Methoxytacrine-p-Anisidine Hybrids as Novel Dual Binding Site Acetylcholinesterase Inhibitors for Alzheimer's Disease Treatment.Small Molecules Targeting Ataxia Telangiectasia and Rad3-Related (ATR) Kinase: An Emerging way to Enhance Existing Cancer Therapy.Novel Tacrine-Scutellarin Hybrids as Multipotent Anti-Alzheimer's Agents: Design, Synthesis and Biological Evaluation.Treatment of organophosphate intoxication using cholinesterase reactivators: facts and fiction.Cholinesterase biosensor construction - a review.Prolyl oligopeptidase and its role in the organism: attention to the most promising and clinically relevant inhibitors.Cholinesterase and Prolyl Oligopeptidase Inhibitory Activities of Alkaloids from Argemone platyceras (Papaveraceae).Acetylcholinesterase Inhibitors and Drugs Acting on Muscarinic Receptors- Potential Crosstalk of Cholinergic Mechanisms During Pharmacological TreatmentSAR study to find optimal cholinesterase reactivator against organophosphorous nerve agents and pesticides.Progress in acetylcholinesterase reactivators and in the treatment of organophosphorus intoxication: a patent review (2006-2016).Reactivation of VX-inhibited AChE by novel oximes having two oxygen atoms in the linker.Why acetylcholinesterase reactivators do not work in butyrylcholinesterase.Isoquinoline Alkaloids from Fumaria officinalis L. and Their Biological Activities Related to Alzheimer's Disease.In Vitro Comparison of Two Most Promising H-Oximes (HI-6 and HLö-7) and Currently Commercially Available Reactivators Pralidoxime and Obidoxime in Reactivation of Cyclosarin-Inhibited Human Cholinesterases.Potency of novel oximes to reactivate sarin inhibited human cholinesterases.Russian VX: inhibition and reactivation of acetylcholinesterase compared with VX agent.Synthesis of (2E)-2-methyl-3-(4-([4-(quinolin-2-ylmethoxy)phenyl]sulfanyl)phenyl)prop-2-enoic acid (VUFB 20609) and 2-methyl-3-(4-([4-(quinolin-2-ylmethoxy)phenyl]sulfanyl)phenyl)propanoic acid (VUFB 20584) as potential antileukotrienic agents.Synthesis, antimicrobial evaluation and molecular modeling of 5-hydroxyisoquinolinium salt series; the effect of the hydroxyl moiety.Design, Synthesis and in vitro Evaluation of Indolotacrine Analogues as Multitarget-Directed Ligands for the Treatment of Alzheimer's Disease.Activity of cholinesterases in a young and healthy middle-European population: Relevance for toxicology, pharmacology and clinical praxis.Daphnia intoxicated by nerve agent tabun can be treated using human antidotes.Organophosphate hydrolases as catalytic bioscavengers of organophosphorus nerve agents.Synthesis and in vitro evaluation of N-(Bromobut-3-en-2-yl)-7-methoxy-1,2,3,4-tetrahydroacridin-9-amine as a cholinesterase inhibitor with regard to Alzheimer's disease treatment.Novel acetylcholinesterase reactivator K112 and its cholinergic properties.Characterization of the anticholinergic properties of obidoxime; functional examinations of the rat atria and the urinary bladder.Amperometric Biosensors for Real Time Assays of Organophosphates.Fluctuation in the ergosterol and deoxynivalenol content in barley and malt during malting process.Pseudo-catalytic scavenging: searching for a suitable reactivator of phosphorylated butyrylcholinesterase.Oxime K027: novel low-toxic candidate for the universal reactivator of nerve agent- and pesticide-inhibited acetylcholinesterase.Novel bisquaternary oximes--reactivation of acetylcholinesterase and butyrylcholinesterase inhibited by paraoxon.New antioxidant flavonoid isolated from Leuzea carthamoides.DPPH Radical Scavenging Activity of Several Naturally Occurring Coumarins and Their Synthesized Analogs Measured by the SIA Method.Time-course changes of acetylcholinesterase activity in blood and some tissues in rats after intoxication by Russian VX.Preparation, in vitro evaluation and molecular modelling of pyridinium-quinolinium/isoquinolinium non-symmetrical bisquaternary cholinesterase inhibitors.Acetylcholinesterases--the structural similarities and differences.Hyaluronidase: its effects on HI-6 dichloride and dimethanesulphonate pharmacokinetic profile in pigs.In vitro oxime-assisted reactivation of paraoxon-inhibited human acetylcholinesterase and butyrylcholinesterase.Methylacridinium and its cholinergic properties.
P50
Q33372019-B77884EE-BB5F-4942-ACA3-3DCEC4AD4883Q33540895-026E2B0D-4F40-4D9B-9D3A-F665FECFF49EQ35874432-9B7228B2-FBBD-411C-9C96-28F09C597A5AQ35924993-127269F7-8F72-45E4-ABD8-93E7A838F6EAQ36407216-0CCD2342-B0A5-47D6-96CE-86D8AD27965DQ36822782-AC81B224-218E-4C5D-B50C-6E36F2D4F0BAQ37294491-33A3A03A-F0C2-4B88-B18F-495DFB440AF7Q38668992-1D35338C-90D9-47E9-94CD-562D27F368F7Q38679235-5BB99961-F690-4798-9E7E-CFD2EBA6F56CQ38860110-1FC0FFA2-9E71-4196-92A0-840D59D26E76Q38942948-DA0E9FC7-E6CD-43B5-B095-526C329CE4AEQ39343521-2C38A72A-4567-4CE4-8D5B-781884936C23Q39725041-BE8CEADF-F3B4-414F-A00E-BE21D1A24F5CQ39934477-5640D2AC-3826-4D9F-B16D-4F51EEFC288AQ40109836-1D62DA6A-ACBA-4832-BD6F-A74080AD51E1Q40139395-B848A7B2-6245-44A1-A56E-C84F631F3297Q40140631-58C97309-2EDC-49B4-B701-0EE45226E19BQ40333075-CA0BA3D5-B3E1-4CEE-9308-C280F3DC5F57Q40539797-2ACF77E6-6064-4940-9382-E840A746601EQ40972566-81AF2311-E35F-4BED-BB06-9FA215D7BEFAQ41276257-6813EC1B-04DB-44C2-9BCA-471F02FF0F7EQ41931228-6056FDA1-CE23-4DD4-9348-37F8E101C1F5Q42729482-A180FBB8-25CB-4368-BC96-D2783D16791BQ42732175-7B2BDD60-86EC-4AE5-AF63-4415B5C11288Q42787028-D50FF3E3-CC72-4FD8-9633-593393D13CF0Q42969156-89CF716F-0C60-4A24-8708-E3631713795AQ42985630-A7BA565B-8F25-4E83-9619-7B22F19E4E18Q43101146-7DDEDB89-882B-42A0-B8DE-8935EEC235ABQ43132051-9F4A9B7E-883E-4771-A36C-94CA3DD8B25DQ43141487-80A5612C-74FE-42D0-A27C-2AD0427A5C35Q43146171-4720887C-55A1-4120-8445-7E29123124A5Q43208760-DF9CAC46-BED4-4C9A-84F6-3522958DCD16Q43210231-C66263C8-5E3C-4EAB-8CA4-49C4ABE71739Q43215929-81C68150-D89F-4DC7-B7A0-F4A9025090F2Q43281541-565C0664-E2E4-4CFD-8298-DEA75DFD191FQ43612984-D594B672-37C3-4FA9-B3E3-38963B04F053Q44138004-6FF663C2-8A20-4C70-BDFC-48CCF31C4D14Q45407763-202097AD-B681-43E1-A850-859E8B623537Q45935496-87A2B76B-69E3-458A-B42F-1AC775A0A90CQ45946937-55BE9F1D-D6AC-448D-925F-8958EA876BA8
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Daniel Jun
@ast
Daniel Jun
@en
Daniel Jun
@es
Daniel Jun
@fr
Daniel Jun
@nl
Daniel Jun
@sl
type
label
Daniel Jun
@ast
Daniel Jun
@en
Daniel Jun
@es
Daniel Jun
@fr
Daniel Jun
@nl
Daniel Jun
@sl
prefLabel
Daniel Jun
@ast
Daniel Jun
@en
Daniel Jun
@es
Daniel Jun
@fr
Daniel Jun
@nl
Daniel Jun
@sl
P1053
S-8647-2017
P106
P21
P31
P3829
P496
0000-0002-0882-6304